Author: GlobeNewswire

BOCA RATON, FL., May 23, 2022 (GLOBE NEWSWIRE) — INmune Bio, Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage immunology company focused…

MIAMI, FL, May 23, 2022 (GLOBE NEWSWIRE) — Tower One Wireless, (OTCQB: TOWTF) announced today that Alejandro Ochoa, Founder and…

NANTES, France, May 23, 2022 (GLOBE NEWSWIRE) — OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) and its clinical partners GERCOR,…

AGOURA HILLS, Calif., May 23, 2022 (GLOBE NEWSWIRE) — Oncotelic Therapeutics, Inc. (“Oncotelic”, “We” or the “Company”) (OTCQB:OTLC) today announced…

Aims to harness the power of the Endocannabinoid System to create life-changing medicinesCUMBERLAND, Md., May 23, 2022 (GLOBE NEWSWIRE) —…

Paul Friel Elevar Therapeutics today announced the hiring of Paul Friel as chief commercial officer. SALT LAKE CITY, May 23,…

The study met its primary endpoint of improved systolic blood pressure (SBP) profile at 6 hours with the istaroxime group…

PITTSBURGH, May 19, 2022 (GLOBE NEWSWIRE) — Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), the leader in redosable gene therapy,…

INDIANAPOLIS, May 19, 2022 (GLOBE NEWSWIRE) — POINT Biopharma Global Inc. (NASDAQ: PNT) (the “Company” or “POINT”), a company accelerating…

EMERALD study met both its primary end points of progression-free survival (PFS) in overall population and in ESR1 mutated patientsPFS…